Holen Sie sich die Stockscreener-App
2.13
5.33%
-0.12
Finanzdaten der Onkure Therapeutics Inc-Aktie (OKUR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
8.22%
16.90
|
15.62 | 14.12 | 15.50 | 16.32 |
| Operating Income/Loss |
8.22%
-16.90
|
-15.62 | -14.12 | -15.50 | -16.32 |
| Net Interest Income/Expense |
239.08%
1.553
|
0.458 | 0.622 | 0.802 | 0.934 |
| Net Income/Loss |
1.25%
-15.35
|
-15.16 | -13.50 | -14.70 | -15.39 |
| Basic Average Shares |
264.69%
49.87
|
13.67 | - | 13.53 | 13.51 |
| Diluted Average Shares |
264.69%
49.87
|
13.67 | - | 13.53 | 13.51 |
| Basic Earnings Per Share |
72.07%
-0.31
|
-1.11 | - | -1.09 | -1.14 |
| Diluted Earnings Per Share |
72.07%
-0.31
|
-1.11 | - | -1.09 | -1.14 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):